NPI: 1477902641 · WATERBURY, CT 06708 · General Acute Care Hospital · NPI assigned 06/08/2016
Authorized official ELDERS, ROBERT controls 20+ related entities in our dataset. Read more
| Authorized Official | ELDERS, ROBERT (SECRETARY) |
| NPI Enumeration Date | 06/08/2016 |
Other providers sharing the same authorized official: ELDERS, ROBERT
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 371,582 | $13.64M |
| 2019 | 398,478 | $13.68M |
| 2020 | 309,955 | $11.21M |
| 2021 | 348,416 | $12.70M |
| 2022 | 329,059 | $11.82M |
| 2023 | 293,299 | $10.80M |
| 2024 | 262,695 | $10.76M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 38,240 | 33,282 | $20.08M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 46,915 | 41,247 | $14.18M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 47,800 | 42,874 | $9.83M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 27,110 | 23,242 | $3.92M |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 4,762 | 4,379 | $2.58M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 9,810 | 8,805 | $2.01M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 7,754 | 7,165 | $1.89M |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 9,631 | 7,829 | $1.31M |
| 70450 | Computed tomography, head or brain; without contrast material | 13,368 | 11,782 | $1.21M |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 1,604 | 1,454 | $1.16M |
| 71046 | Radiologic examination, chest; 2 views | 21,500 | 19,230 | $1.13M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 9,168 | 8,507 | $1.12M |
| H0015 | Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education | 8,292 | 1,336 | $1.03M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 7,462 | 5,843 | $978K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 13,233 | 7,741 | $970K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 8,670 | 8,044 | $970K |
| S9480 | Intensive outpatient psychiatric services, per diem | 7,744 | 1,073 | $962K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 23,746 | 21,013 | $912K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 6,274 | 5,724 | $911K |
| 58661 | 176 | 173 | $891K | |
| 93975 | 3,430 | 3,123 | $724K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 34,480 | 18,903 | $705K |
| 96375 | Therapeutic injection; each additional sequential IV push | 15,957 | 13,736 | $697K |
| 96361 | Intravenous infusion, hydration; each additional hour | 17,773 | 14,882 | $692K |
| 71045 | Radiologic examination, chest; single view | 12,010 | 10,451 | $561K |
| 80053 | Comprehensive metabolic panel | 82,373 | 72,354 | $517K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 2,986 | 1,402 | $457K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 13,543 | 12,864 | $378K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 13,519 | 12,840 | $378K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 1,560 | 1,471 | $343K |
| 86900 | 12,805 | 8,493 | $332K | |
| 36415 | Collection of venous blood by venipuncture | 182,325 | 132,757 | $328K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 16,134 | 15,071 | $308K |
| 84443 | Thyroid stimulating hormone (TSH) | 30,112 | 27,840 | $307K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 441 | 400 | $303K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 559 | 520 | $297K |
| 93458 | 244 | 196 | $264K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 2,937 | 2,672 | $247K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 2,764 | 2,315 | $247K |
| 80061 | Lipid panel | 27,552 | 25,556 | $246K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 2,817 | 2,522 | $240K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 471 | 438 | $238K |
| 80048 | Basic metabolic panel (calcium, ionized) | 46,734 | 37,446 | $223K |
| 70486 | 1,554 | 1,414 | $222K | |
| 95816 | 1,320 | 1,199 | $217K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 2,099 | 1,861 | $217K |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | 981 | 877 | $205K |
| 59025 | Fetal non-stress test | 1,388 | 882 | $182K |
| 71250 | 3,305 | 3,047 | $172K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 103,733 | 86,213 | $171K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 30,549 | 27,246 | $167K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 16,313 | 9,333 | $163K |
| 93971 | 2,243 | 1,991 | $158K | |
| 76830 | Ultrasound, transvaginal | 1,570 | 1,460 | $157K |
| 95811 | 234 | 215 | $154K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 6,663 | 6,039 | $143K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2,096 | 1,924 | $142K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 16,903 | 13,972 | $137K |
| 93017 | 6,438 | 5,900 | $137K | |
| 70498 | 1,017 | 915 | $132K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1,505 | 1,418 | $122K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2,974 | 2,681 | $121K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 41,819 | 33,524 | $118K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 6,508 | 6,176 | $115K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 3,898 | 3,763 | $110K |
| 87625 | 3,901 | 3,763 | $99K | |
| 58571 | 15 | 13 | $99K | |
| 87536 | 1,487 | 1,422 | $96K | |
| 72100 | 3,965 | 3,696 | $94K | |
| J2357 | Injection, omalizumab, 5 mg | 649 | 287 | $89K |
| 82607 | 9,844 | 9,057 | $86K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 15,775 | 14,578 | $86K |
| 58558 | 43 | 41 | $84K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1,064 | 997 | $83K |
| 82570 | 26,874 | 13,674 | $82K | |
| 86480 | 1,879 | 1,786 | $80K | |
| 85027 | 33,388 | 28,668 | $79K | |
| 36416 | 21,814 | 12,823 | $78K | |
| 84439 | 13,421 | 12,503 | $77K | |
| 71271 | 688 | 659 | $71K | |
| 97602 | 513 | 315 | $62K | |
| 86803 | 6,095 | 5,748 | $62K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 4,638 | 4,464 | $60K |
| C1769 | Guide wire | 1,316 | 962 | $56K |
| 73560 | 5,081 | 3,931 | $55K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 4,762 | 4,232 | $54K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 15,739 | 14,086 | $53K |
| 76770 | 580 | 511 | $51K | |
| 86360 | 1,413 | 1,360 | $51K | |
| 86235 | 2,553 | 1,235 | $50K | |
| 86618 | 5,014 | 2,383 | $49K | |
| 93970 | 389 | 346 | $48K | |
| 73130 | 3,903 | 3,025 | $48K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 143 | 131 | $46K |
| 73610 | 3,375 | 2,944 | $44K | |
| 73030 | 4,011 | 3,435 | $44K | |
| 82947 | 19,973 | 10,343 | $42K | |
| 83655 | 3,905 | 3,771 | $42K | |
| 80076 | 18,724 | 16,501 | $39K | |
| 88304 | 2,124 | 1,950 | $39K | |
| 76536 | 508 | 488 | $39K | |
| 73630 | 3,292 | 2,839 | $39K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 831 | 577 | $38K |
| 82746 | 4,574 | 4,203 | $38K | |
| 82728 | 4,522 | 4,122 | $37K | |
| 87070 | 6,549 | 6,120 | $37K | |
| 88342 | 1,317 | 1,138 | $36K | |
| 87077 | 8,383 | 7,701 | $36K | |
| 84403 | 1,882 | 1,743 | $35K | |
| 87340 | 4,740 | 4,499 | $35K | |
| 81001 | 30,876 | 27,510 | $34K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 378 | 356 | $33K |
| 73502 | 2,574 | 2,140 | $32K | |
| 84153 | 3,104 | 2,890 | $31K | |
| 83970 | 1,378 | 1,249 | $31K | |
| 73110 | 1,975 | 1,688 | $29K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 1,701 | 510 | $29K |
| 0001A | 1,081 | 913 | $29K | |
| 84480 | 2,867 | 2,676 | $27K | |
| 86318 | 2,467 | 1,776 | $27K | |
| 83550 | 4,886 | 4,474 | $26K | |
| 86592 | 7,214 | 6,850 | $26K | |
| 93976 | 274 | 247 | $25K | |
| 93308 | 209 | 200 | $25K | |
| 87081 | 9,163 | 8,650 | $22K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 694 | 625 | $22K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 82 | 64 | $22K |
| 86038 | 2,795 | 2,618 | $22K | |
| 83540 | 5,278 | 4,833 | $21K | |
| 78431 | 68 | 63 | $20K | |
| 87186 | 4,677 | 4,228 | $19K | |
| 70496 | 341 | 311 | $18K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 2,378 | 2,064 | $18K |
| 82043 | 5,448 | 5,000 | $17K | |
| G0378 | Hospital observation service, per hour | 9,627 | 6,690 | $16K |
| 76819 | Fetal biophysical profile; without non-stress testing | 151 | 77 | $16K |
| 85651 | 8,481 | 7,678 | $15K | |
| 72040 | 857 | 794 | $15K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 532 | 480 | $15K |
| 85610 | 28,956 | 21,432 | $15K | |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 154 | 143 | $15K |
| 73562 | 734 | 665 | $15K | |
| 88307 | 780 | 663 | $14K | |
| 74018 | 537 | 468 | $14K | |
| 83880 | 11,502 | 10,084 | $14K | |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | 215 | 207 | $14K |
| 86800 | 1,511 | 1,409 | $14K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 144 | 138 | $14K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 25 | 25 | $14K |
| 83721 | 2,525 | 2,331 | $14K | |
| 73070 | 1,292 | 1,115 | $13K | |
| 84270 | 765 | 705 | $13K | |
| 0002A | 463 | 375 | $12K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 979 | 908 | $12K |
| 86706 | 1,682 | 1,562 | $12K | |
| G0144 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system, under physician supervision | 905 | 868 | $12K |
| 97161 | 1,683 | 1,443 | $12K | |
| 86376 | 1,421 | 1,334 | $11K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 11,317 | 7,860 | $11K |
| 83735 | 17,030 | 12,965 | $11K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 159 | 136 | $11K |
| 86617 | 1,170 | 546 | $11K | |
| 87522 | Neg quan hep c or qual rna | 328 | 303 | $11K |
| 86200 | 1,843 | 1,719 | $11K | |
| 86140 | 5,108 | 4,470 | $11K | |
| 88112 | 733 | 671 | $10K | |
| 93307 | 77 | 71 | $10K | |
| 83525 | 1,155 | 1,086 | $10K | |
| 72070 | 679 | 631 | $10K | |
| 90675 | 37 | 12 | $9K | |
| 81003 | 25,760 | 22,970 | $9K | |
| 70491 | 60 | 50 | $9K | |
| 84702 | 5,055 | 4,317 | $8K | |
| 86703 | 975 | 923 | $8K | |
| 86334 | 722 | 677 | $8K | |
| 97162 | 577 | 506 | $8K | |
| 80074 | 245 | 230 | $8K | |
| 86431 | 2,562 | 2,401 | $7K | |
| 73590 | 739 | 643 | $7K | |
| 81025 | 19,103 | 17,057 | $7K | |
| 84484 | 32,916 | 23,772 | $7K | |
| 72131 | 126 | 113 | $7K | |
| 83516 | 682 | 486 | $7K | |
| 84481 | 577 | 535 | $7K | |
| 82550 | 5,058 | 4,391 | $7K | |
| 84146 | 468 | 427 | $6K | |
| 73140 | 503 | 447 | $6K | |
| 93880 | 97 | 83 | $6K | |
| 86003 | 128 | 67 | $6K | |
| 82652 | 216 | 205 | $6K | |
| 83690 | 22,819 | 19,844 | $6K | |
| 72050 | 205 | 191 | $6K | |
| 82565 | 4,495 | 4,007 | $6K | |
| 85730 | 7,365 | 6,458 | $6K | |
| 85018 | 5,163 | 4,392 | $6K | |
| 83021 | 371 | 354 | $6K | |
| 82731 | 275 | 222 | $5K | |
| 96376 | 3,395 | 2,811 | $5K | |
| 10060 | 39 | 36 | $5K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 689 | 602 | $5K |
| 12001 | 921 | 849 | $5K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 4,820 | 3,694 | $5K |
| 85007 | 3,425 | 3,039 | $5K | |
| 86696 | 304 | 277 | $4K | |
| 86160 | 312 | 277 | $4K | |
| 80051 | 2,251 | 1,957 | $4K | |
| 10061 | 13 | 12 | $4K | |
| 87205 | 2,174 | 1,898 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 11,877 | 5,418 | $4K |
| 82150 | 3,635 | 3,381 | $4K | |
| 82040 | 1,185 | 1,096 | $3K | |
| Q9950 | Injection, sulfur hexafluoride lipid microspheres, per ml | 297 | 273 | $3K |
| 82105 | 214 | 213 | $3K | |
| 84460 | 1,913 | 1,724 | $3K | |
| 83001 | 212 | 201 | $3K | |
| 87088 | 842 | 771 | $3K | |
| 74174 | 14 | 12 | $3K | |
| 86901 | 12,778 | 8,492 | $3K | |
| 80164 | 439 | 395 | $3K | |
| 84100 | 9,628 | 7,114 | $3K | |
| 82784 | 411 | 366 | $3K | |
| 87075 | 550 | 457 | $3K | |
| 84550 | 3,062 | 2,634 | $3K | |
| 86255 | 312 | 293 | $3K | |
| 84156 | 1,731 | 1,397 | $3K | |
| 86704 | 313 | 298 | $2K | |
| 97597 | 35 | 24 | $2K | |
| 76641 | 34 | 25 | $2K | |
| 71101 | 351 | 310 | $2K | |
| 83020 | 207 | 188 | $2K | |
| 80050 | General health panel | 719 | 658 | $2K |
| 87040 | 5,101 | 3,017 | $2K | |
| 86328 | 80 | 72 | $2K | |
| 86225 | 218 | 201 | $2K | |
| 73090 | 299 | 271 | $2K | |
| 84703 | 8,189 | 7,457 | $2K | |
| 87634 | 39 | 39 | $2K | |
| 12002 | 188 | 178 | $2K | |
| 84450 | 1,845 | 1,664 | $2K | |
| 87631 | 1,076 | 1,004 | $1K | |
| 85379 | 4,480 | 4,019 | $1K | |
| 84165 | 320 | 295 | $1K | |
| 83605 | 9,488 | 7,949 | $1K | |
| 86695 | 143 | 128 | $1K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 480 | 391 | $1K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 14 | 12 | $1K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2,861 | 2,388 | $1K |
| 96415 | 28 | 24 | $1K | |
| 0031A | 56 | 56 | $1K | |
| 82977 | 247 | 226 | $1K | |
| 90791 | Psychiatric diagnostic evaluation | 314 | 268 | $1K |
| J2785 | Injection, regadenoson, 0.1 mg | 4,010 | 3,668 | $1K |
| 97116 | 167 | 121 | $1K | |
| 87430 | 5,802 | 5,430 | $1K | |
| 86665 | 78 | 39 | $1K | |
| J3490 | Unclassified drugs | 112,598 | 42,631 | $1K |
| 84134 | 137 | 88 | $1K | |
| 86735 | 99 | 91 | $1K | |
| 0012A | 60 | 52 | $1K | |
| 74019 | 41 | 38 | $1K | |
| 86850 | 8,872 | 7,818 | $1K | |
| 86708 | 106 | 102 | $1K | |
| 88302 | 303 | 286 | $1K | |
| 12011 | 324 | 311 | $972.03 | |
| 84432 | 88 | 83 | $966.42 | |
| 86765 | 90 | 82 | $935.56 | |
| 36430 | 14 | 12 | $917.72 | |
| 72170 | 116 | 101 | $879.57 | |
| 85014 | 531 | 497 | $874.62 | |
| 86790 | 570 | 503 | $838.17 | |
| 96367 | 15 | 15 | $837.84 | |
| C1781 | Mesh (implantable) | 13 | 12 | $827.68 |
| 86308 | 799 | 739 | $818.25 | |
| 86039 | 112 | 105 | $755.26 | |
| 84132 | 417 | 352 | $712.14 | |
| 83002 | 56 | 52 | $712.07 | |
| 86920 | 112 | 88 | $682.58 | |
| 82140 | 160 | 129 | $668.16 | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 14 | 12 | $601.80 |
| 80177 | 100 | 90 | $564.23 | |
| 88142 | 44 | 42 | $563.34 | |
| 84112 | 66 | 52 | $553.68 | |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 37 | 13 | $553.35 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1,597 | 688 | $540.00 |
| C1760 | Closure device, vascular (implantable/insertable) | 34 | 28 | $519.18 |
| 82247 | 222 | 175 | $508.54 | |
| 85041 | 218 | 209 | $506.00 | |
| 76642 | 12 | 12 | $490.90 | |
| 86664 | 39 | 39 | $467.52 | |
| 87427 | 50 | 25 | $412.20 | |
| 86666 | 40 | 27 | $408.24 | |
| 87329 | 43 | 39 | $377.85 | |
| 87328 | 43 | 39 | $377.85 | |
| 82803 | 599 | 490 | $375.52 | |
| 82670 | 15 | 14 | $373.52 | |
| 90715 | 2,520 | 2,336 | $338.31 | |
| 90792 | Psychiatric diagnostic evaluation with medical services | 35 | 33 | $318.79 |
| 84520 | 2,521 | 2,214 | $313.38 | |
| 82248 | 381 | 308 | $310.60 | |
| 74420 | 30 | 24 | $303.66 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 45,473 | 20,223 | $289.62 |
| 76870 | 42 | 39 | $274.52 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 17,087 | 14,801 | $262.69 |
| 83615 | 239 | 197 | $257.90 | |
| 97165 | 61 | 55 | $253.94 | |
| 86709 | 30 | 29 | $247.25 | |
| 84155 | 260 | 233 | $240.01 | |
| 87046 | 39 | 37 | $239.73 | |
| 93225 | 43 | 35 | $222.54 | |
| 87045 | 39 | 37 | $216.48 | |
| 87102 | 29 | 25 | $192.48 | |
| 86317 | 15 | 14 | $186.16 | |
| 0011A | 25 | 21 | $186.00 | |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 36 | 16 | $182.91 |
| 51702 | 33 | 25 | $176.92 | |
| 86812 | 15 | 12 | $172.55 | |
| 73552 | 59 | 50 | $164.53 | |
| 85045 | 77 | 71 | $157.94 | |
| 82785 | 15 | 12 | $157.30 | |
| 86753 | 18 | 14 | $153.79 | |
| 99215 | Prolong outpt/office vis | 93 | 83 | $152.85 |
| 83921 | 13 | 13 | $141.48 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 28,531 | 23,087 | $136.73 |
| 84145 | 105 | 90 | $127.90 | |
| 82010 | 801 | 665 | $124.30 | |
| 76937 | 41 | 36 | $121.00 | |
| 80143 | 1,377 | 1,254 | $101.64 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 1,497 | 1,233 | $92.16 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 4,912 | 4,485 | $89.70 |
| 73060 | 13 | 13 | $88.74 | |
| J2704 | Injection, propofol, 10 mg | 13,254 | 10,333 | $82.45 |
| 88341 | 502 | 411 | $80.60 | |
| 80320 | 4,506 | 3,944 | $80.25 | |
| 87420 | 528 | 492 | $80.15 | |
| 71100 | 15 | 13 | $69.15 | |
| 86705 | 12 | 12 | $67.50 | |
| 82085 | 15 | 13 | $64.89 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 3,541 | 3,207 | $63.84 |
| 84436 | 16 | 15 | $59.04 | |
| 80179 | 1,299 | 1,188 | $57.91 | |
| 87220 | 14 | 13 | $56.98 | |
| 82950 | 12 | 12 | $54.48 | |
| 80178 | 16 | 14 | $44.17 | |
| 85008 | 1,201 | 1,049 | $31.09 | |
| A9270 | Non-covered item or service | 55,411 | 9,137 | $30.44 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 22,542 | 19,144 | $29.56 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 21,477 | 17,768 | $23.83 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 11,721 | 8,647 | $20.11 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 4,704 | 3,975 | $19.74 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 2,047 | 1,833 | $15.41 |
| 84311 | 14 | 12 | $13.36 | |
| J1644 | Injection, heparin sodium, per 1000 units | 8,293 | 4,165 | $12.82 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 8,279 | 6,064 | $11.50 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 3,331 | 2,759 | $10.14 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 3,908 | 3,365 | $9.24 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 3,011 | 2,622 | $8.17 |
| 80305 | 309 | 157 | $7.55 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 4,401 | 3,756 | $7.33 |
| 83986 | 14 | 12 | $6.84 | |
| J1630 | Injection, haloperidol, up to 5 mg | 2,133 | 1,775 | $6.40 |
| J2060 | Injection, lorazepam, 2 mg | 3,449 | 2,833 | $5.93 |
| J1170 | Injection, hydromorphone, up to 4 mg | 5,881 | 4,159 | $5.42 |
| 80365 | 258 | 210 | $5.05 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 6,327 | 5,091 | $3.88 |
| J8540 | Dexamethasone, oral, 0.25 mg | 737 | 493 | $3.84 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 8,142 | 7,235 | $3.07 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 1,124 | 968 | $2.62 |
| J0690 | Injection, cefazolin sodium, 500 mg | 5,620 | 4,424 | $1.88 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 11,381 | 9,473 | $1.60 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 858 | 750 | $1.38 |
| S0164 | Injection, pantoprazole sodium, 40 mg | 819 | 694 | $0.77 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 9,939 | 8,578 | $0.34 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 759 | 652 | $0.24 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 759 | 653 | $0.24 |
| J1815 | Injection, insulin, per 5 units | 1,865 | 994 | $0.14 |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 114 | 91 | $0.02 |
| J7050 | Infusion, normal saline solution, 250 cc | 3,014 | 2,249 | $0.00 |
| A9698 | Non-radioactive contrast imaging material, not otherwise classified, per study | 489 | 430 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 297 | 252 | $0.00 |
| J0280 | Injection, aminophyllin, up to 250 mg | 1,253 | 1,167 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 74 | 55 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 2,939 | 2,572 | $0.00 |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 68 | 63 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 218 | 180 | $0.00 |
| 77001 | 41 | 29 | $0.00 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 91 | 72 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 43 | 41 | $0.00 |
| 91307 | 189 | 166 | $0.00 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 144 | 123 | $0.00 |
| C2617 | Stent, non-coronary, temporary, without delivery system | 30 | 24 | $0.00 |
| 51798 | 30 | 12 | $0.00 | |
| 80329 | 77 | 45 | $0.00 | |
| C9290 | Injection, bupivacaine liposome, 1 mg | 159 | 134 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 29 | 28 | $0.00 |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 85 | 75 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 77 | 61 | $0.00 |
| C1889 | Implantable/insertable device, not otherwise classified | 24 | 24 | $0.00 |
| Q0247 | Injection, sotrovimab, 500 mg | 16 | 15 | $0.00 |
| 93000 | 16 | 12 | $0.00 | |
| J1940 | Injection, furosemide, up to 20 mg | 34 | 25 | $0.00 |
| J7121 | 5% dextrose in lactated ringers infusion, up to 1000 cc | 24 | 14 | $0.00 |
| J0706 | Injection, caffeine citrate, 5 mg | 14 | 12 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 198 | 177 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 1,619 | 1,419 | $0.00 |
| J1956 | Injection, levofloxacin, 250 mg | 476 | 399 | $0.00 |
| A4550 | Surgical trays | 90 | 89 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 1,516 | 1,366 | $0.00 |
| 80354 | 1,051 | 890 | $0.00 | |
| 88313 | 213 | 196 | $0.00 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 187 | 165 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 148 | 117 | $0.00 |
| 99001 | 54 | 50 | $0.00 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 128 | 116 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 111 | 104 | $0.00 |
| 87210 | 16 | 15 | $0.00 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 223 | 99 | $0.00 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 71 | 59 | $0.00 |
| 80362 | 20 | 14 | $0.00 | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 15 | 13 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 185 | 113 | $0.00 |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 171 | 102 | $0.00 |
| 80348 | 102 | 75 | $0.00 | |
| 36600 | 14 | 13 | $0.00 | |
| 82948 | 58 | 30 | $0.00 | |
| 76942 | 20 | 12 | $0.00 | |
| J7070 | Infusion, d5w, 1000 cc | 21 | 16 | $0.00 |
| 80346 | 55 | 50 | $0.00 | |
| 78434 | 55 | 50 | $0.00 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 165 | 139 | $0.00 |
| 81401 | 12 | 12 | $0.00 | |
| 91300 | 62 | 62 | $0.00 | |
| C9113 | Injection, pantoprazole sodium, per vial | 105 | 81 | $0.00 |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | 23 | 19 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 16 | 15 | $0.00 |
| 99152 | 37 | 36 | $0.00 |